Nervus intermedius sectioning for the treatment of geniculate neuralgia

J Neurosurg 143:111–118, 2025

Nervus intermedius (NI) sectioning for geniculate neuralgia (GN) provided pain relief in 81% and complete resolution in 68% of cases, with low complication rates. Combining NI sectioning with microvascular decompression improved outcomes. The study supports NI sectioning as a safe, effective surgical option when medical management fails.

Geniculate neuralgia (GN) is a rare facial pain syndrome with severe stabbing ear pain, often involving the nervus intermedius (NI) as the primary structure.

Medical management is first-line, but when ineffective, surgical options like NI sectioning and microvascular decompression (MVD) are considered.

• This study presents the largest case series (47 procedures in 45 patients) of NI sectioning for GN, with most patients also having trigeminal neuralgia or glossopharyngeal neuralgia.

NI sectioning led to pain improvement (BNI score < IV) in 80.9% and complete pain resolution (BNI I) in 68.1% of procedures at latest follow-up.

Combining NI sectioning with MVD further improved outcomes, especially in patients with concurrent neuralgias.

Complications were rare: 2 cases of hearing loss, 1 confirmed permanent vestibular dysfunction, and 3 cases of loss of taste; no permanent facial paralysis or loss of lacrimation.

Older age predicted worse pain outcomes after surgery.

• The study supports NI sectioning as a safe and effective treatment for GN, especially when tailored with MVD as needed.